IRCT20181208041886N3招募中3 期
Evaluation of the effect of Montelukast drug in improving the clinical condition of patients with COVID-19 in referral hospitals in Isfahan
Abidi Pharmaceutical company0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 no limit（—）
- 性别
- All
入选标准
- •Every patient with diagnosis of COVID-19
- •Mild, moderate and severe stage of the disease
排除标准
- •No complete consent and compliace of the patient for study
- •Follow up of the patient not be possible
- •The age below 15 years old
- •Rifampin and Phenobarbital consumers
研究者
相似试验
尚未招募
3 期
The effect of Montelukast in the treatment of cystitisCystitisCystitis.IRCT20220203053919N1Arak University of Medical Sciences56
已完成
3 期
Therapeutic effect of Montelukast in patients with oral lichen planusLichen Planusichen Planus.IRCT2012110811389N2Vice Chancellor for Research , Hamedan University of Medical Sciences200
招募中
4 期
The effect of Monteluca on the symptoms of pyelonephritis in childreIRCT20190303042893N1Arak University of Medical Sciences100
进行中（未招募）
1 期
Efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19)EUCTR2020-001747-21-PTInstituto de Saúde Pública Universidade Porto160
已完成
3 期
Evaluation of montelukast efficacy on clinical and FEV1/PEFR improvement in acute basthma attackAcute attack asthma.AsthmaIRCT2015092215446N5Vice chanceller for research, Ahvaz Jundishapur University of Medical Sciences80